These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 12678232

  • 1. Serological methods for potency testing of tetanus toxoid vaccines for human use.
    Hendriksen C, Winsnes R.
    Dev Biol (Basel); 2002; 111():131-40. PubMed ID: 12678232
    [Abstract] [Full Text] [Related]

  • 2. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use.
    Winsnes R, Hendriksen C, Sesardic D, Akkermans A, Daas A.
    Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802
    [Abstract] [Full Text] [Related]

  • 3. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R, Hockley J, Rigsby P, Terao E, Daas A, Buchheit KH, Sesardic D.
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [Abstract] [Full Text] [Related]

  • 4. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R, Sesardic D, Daas A, Behr-Gross ME.
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A Vero cell method for potency testing of diphtheria vaccines.
    Winsnes R, Sesardic D, Daas A, Rigsby P.
    Dev Biol (Basel); 2002 Jan; 111():141-8. PubMed ID: 12678233
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U, Volkers P, Noeske K, Werner E.
    ALTEX; 2004 Jan; 21 Suppl 3():65-9. PubMed ID: 15057410
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
    Rosskopf U, Noeske K, Werner E.
    ALTEX; 2005 Jan; 22(3):169-74. PubMed ID: 16186992
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulins.
    Gross S, Janssen SW, de Vries B, Terao E, Daas A, Buchheit KH.
    Biologicals; 2010 Jul; 38(4):501-10. PubMed ID: 20399681
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Alternative approach and evaluation of three potency assay methods for testing adsorbed tetanus toxoid.
    Maheshwari SC, Sharma SB, Kumar A, Sokhey J.
    J Commun Dis; 1998 Mar; 30(1):12-8. PubMed ID: 9842159
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.